RMD ResMed
- 216.840
- +3.960+1.86%
- 216.540
- -0.300-0.14%
ResMed News
Resmed Inc Updates Dividend Exchange Rate
ResMed(RMD.US) Officer Sells US$3.18 Million in Common Stock
$ResMed(RMD.US)$ Officer Farrell Michael J. sold 14,683 shares of common stock on May 7, 2024 at an average price of $216.4963 for a total value of $3.18 million.Source: Announcement What is statement
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing
Michael J. Farrell, Chief Executive Officer, on May 07, 2024, sold 14,683 shares in Resmed (RMD) for $3,178,815. Following the Form 4 filing with the SEC, Farrell has control over a total of 444,842 s
Form 144 | ResMed(RMD.US) Officer Proposes to Sell 2.75 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 8, $ResMed(RMD.US)$、$RESMED INC CDI COM USD0.004 (10CDI/1SHS)(RSMDF.US)$ Officer Sandercock Brett intends to sell 13,000 shares of its common stock on May 8, with a total m
3 GARP Stocks to Scoop up for Maximum Returns
Growth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits.
ResMed Announces Participation in the RBCCM Global Healthcare Conference
Form 144 | ResMed(RMD.US) Officer Proposes to Sell 3.19 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $ResMed(RMD.US)$、$RESMED INC CDI COM USD0.004 (10CDI/1SHS)(RSMDF.US)$ Officer Farrell Michael J. intends to sell 14,683 shares of its common stock on May 7, with a total
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
Goldman's Top 50 Stable Growth Stocks
ResMed Inc. (NYSE:RMD) Looks Interesting, And It's About To Pay A Dividend
ResMed Inc Reports Monthly CDI Fluctuations
ResMed Third Quarter 2024 Earnings: Beats Expectations
ResMed(RMD.US) Director Sells US$91,341 in Common Stock
$ResMed(RMD.US)$ Director Drexler Karen sold 425 shares of common stock on Apr 29, 2024 at an average price of $214.92 for a total value of $91,341.Source: Announcement What is statement of changes in
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
Why ResMed (RMD) Is a Top Momentum Stock for the Long-Term
(RMD) - Analyzing ResMed's Short Interest
ResMed's (NYSE:RMD) short percent of float has risen 3.03% since its last report. The company recently reported that it has 7.89 million shares sold short, which is 6.12% of all regular shares that ar
ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next
The "highest Quality" Stocks Within Each Sector - GS
Here's Why ResMed (RMD) Is a Strong Growth Stock
Positive Week for ResMed Inc. (NYSE:RMD) Institutional Investors Who Lost 6.0% Over the Past Year
Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their trading decisions The top 25 shareholders own 44% of the company Insiders have b
Analysis
Price Target
No Data
